Is MORF or RYLD a better dividend investment in 2026?

MORF currently yields 3.51% with a 5% 5-year dividend growth rate. RYLD yields 12.39% with 5% growth. The better choice depends on your goal: RYLD offers higher current income.

What is the dividend yield difference between MORF and RYLD?

MORF has a forward dividend yield of 3.51% ($2.00/share annually). RYLD yields 12.39% ($1.81/share annually). The yield gap is 8.88 percentage points.

Home › Compare › MORF vs RYLD

MORF vs RYLD: Dividend Comparison 2026

MORF yields 3.51% · RYLD yields 12.39%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RYLD wins by $20.2K in total portfolio value

INVESTMENT

TIME HORIZON10 years

MORF

● Live price

3.51%

Share price

$56.99

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.1K

Annual income

$439.80

Full MORF calculator →

RYLD

● Live price

12.39%

Share price

$14.64

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.3K

Annual income

$2,682.98

Full RYLD calculator →

Portfolio growth — MORF vs RYLD

📍 RYLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MORF	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MORF + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MORF pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MORF

Annual income on $10K today (after 15% tax)

$298.30/yr

After 10yr DRIP, annual income (after tax)

$373.83/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,053.44/yr

After 10yr DRIP, annual income (after tax)

$2,280.53/yr

At 15% tax rate, RYLD beats the other by $1,906.70/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MORF + RYLD for your $10,000?

MORF: 50%RYLD: 50%

100% RYLD50/50100% MORF

Portfolio after 10yr

$35.2K

Annual income

$1,561.39/yr

Blended yield

4.44%

📊

Analyst Conviction Gap

Where Wall Street is split right now

MORF

No analyst data

Price Target

$57.00

+0.0% upside vs current

Range: $57.00 — $57.00

Altman Z

60.9

Piotroski

2/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MORF buys

RYLD buys

No recent congressional trades found for MORF or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMORFRYLD

Forward yield	3.51%	12.39% ✓
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$25.1K	$45.3K ✓
Annual income after 10y	$439.80	$2,682.98 ✓
Total dividends collected	$4.0K	$19.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: MORF vs RYLD ($10,000, DRIP)

Year	MORF Portfolio	MORF Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$11,051	$350.94	$11,939	$1,239.34	$888.00 → RYLD
2	$12,187	$362.45	$14,158	$1,382.89	$2.0K → RYLD
3	$13,414	$373.56	$16,682	$1,532.59	$3.3K → RYLD
4	$14,737	$384.26	$19,537	$1,687.64	$4.8K → RYLD
5	$16,163	$394.55	$22,752	$1,847.20	$6.6K → RYLD
6	$17,699	$404.42	$26,355	$2,010.43	$8.7K → RYLD
7	$19,352	$413.88	$30,376	$2,176.45	$11.0K → RYLD
8	$21,129	$422.92	$34,847	$2,344.43	$13.7K → RYLD
9	$23,040	$431.56	$39,800	$2,513.54	$16.8K → RYLD
10	$25,092	$439.80	$45,269	$2,682.98	$20.2K → RYLD

MORF vs RYLD: Complete Analysis 2026

MORF — Stock

Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; and preclinical trial to treat idiopathic pulmonary fibrosis and fibrosis diseases. The company is also developing avß6 for the treatment of fibrotic diseases, and avß8 to treat solid tumors, as well as various other products. Morphic Holding, Inc. has a research collaboration with Engitix Ltd for the identification of Morphic integrin technology amenable targets in fibrostenotic IBD; a collaboration agreement with Schrödinger, LLC for integrin targets; and a license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. It also has collaboration agreements with AbbVie Biotechnology Ltd and Janssen Pharmaceuticals, Inc. to discover or develop integrin-based therapeutics. Morphic Holding, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Full MORF Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this MORF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MORF vs SCHD MORF vs JEPI MORF vs O MORF vs KO MORF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.